{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T02:06:57Z","timestamp":1788660417513,"version":"build-2803163510"},"reference-count":42,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"Context:<\/jats:title>Some men who use finasteride for hair loss report persistent sexual and other symptoms after discontinuing finasteride therapy.<\/jats:p><\/jats:sec>Objective:<\/jats:title>To determine whether these persistent symptoms after discontinuation of finasteride use are due to androgen deficiency, decreased peripheral androgen action, or persistent inhibition of steroid 5\u03b1-reductase (SRD5A) enzymes.<\/jats:p><\/jats:sec>Participants:<\/jats:title>Finasteride users, who reported persistent sexual symptoms after discontinuing finasteride (group 1); age-matched finasteride users who did not report sexual symptoms (group 2); and healthy men who had never used finasteride (group 3).<\/jats:p><\/jats:sec>Outcomes:<\/jats:title>Sexual function, mood, affect, cognition, hormone levels, body composition, functional magnetic resonance imaging (fMRI) response to sexually and affectively valenced stimuli, nucleotide sequences of androgen receptor (AR), SRD5A1, and SRD5A2; expression levels of androgen-dependent genes in skin.<\/jats:p><\/jats:sec>Setting:<\/jats:title>Academic medical center.<\/jats:p><\/jats:sec>Results:<\/jats:title>Symptomatic finasteride users were similar in body composition, strength, and nucleotide sequences of AR, SRD5A1, and SRD5A2 genes to asymptomatic finasteride users and nonusers. Symptomatic finasteride users had impaired sexual function, higher depression scores, a more negative affectivity balance, and more cognitive complaints than men in groups 2 and 3 but had normal objectively assessed cognitive function. Testosterone, dihydrotestosterone, 5\u03b1-androstane-3\u03b1,17\u03b2-diol-glucuronide, testosterone to dihydrotestosterone and androsterone glucuronide to etiocholanolone glucuronide ratios, and markers of peripheral androgen action and expression levels of AR-dependent genes in skin did not differ among groups. fMRI blood oxygen level-dependent responses to erotic and nonerotic stimuli revealed abnormal function in brain circuitry linked to sexual arousal and major depression.<\/jats:p><\/jats:sec>Conclusions:<\/jats:title>We found no evidence of androgen deficiency, decreased peripheral androgen action, or persistent peripheral inhibition of SRD5A in men with persistent sexual symptoms after finasteride use. Symptomatic finasteride users revealed depressed mood and fMRI findings consistent with those observed in depression.<\/jats:p><\/jats:sec>","DOI":"10.1210\/jc.2016-2726","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T17:37:53Z","timestamp":1474652273000},"page":"4669-4680","source":"Crossref","is-referenced-by-count":57,"title":["Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss"],"prefix":"10.1210","volume":"101","author":[{"given":"Shehzad","family":"Basaria","sequence":"first","affiliation":[{"name":"Research Program in Men\u2019s Health: Aging and Metabolism (S.Ba., R.K., G.H., K.P., Z.L., C.S., A.P., T.W.S., S.Bh.), Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Jasuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Huang","sequence":"additional","affiliation":[{"name":"Research Program in Men\u2019s Health: Aging and Metabolism (S.Ba., R.K., G.H., K.P., Z.L., C.S., A.P., T.W.S., S.Bh.), Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Wharton","sequence":"additional","affiliation":[{"name":"Department of Neurology (W.W.), Emory University, Atlanta, Georgia 30322"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Pan","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Functional Neuroimaging Laboratory (H.P., E.S.), Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Pencina","sequence":"additional","affiliation":[{"name":"Research Program in Men\u2019s Health: Aging and Metabolism (S.Ba., R.K., G.H., K.P., Z.L., C.S., A.P., T.W.S., S.Bh.), Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoying","family":"Li","sequence":"additional","affiliation":[{"name":"Research Program in Men\u2019s Health: Aging and Metabolism (S.Ba., R.K., G.H., K.P., Z.L., C.S., A.P., T.W.S., S.Bh.), Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Travison","sequence":"additional","affiliation":[{"name":"Program on Aging (T.G.T.), Hebrew Senior Life, Roslindale, Massachusetts 02131"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jag","family":"Bhawan","sequence":"additional","affiliation":[{"name":"Department of Dermatology (J.B.), Boston University School of Medicine, Boston, Massachusetts 02118"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Gonthier","sequence":"additional","affiliation":[{"name":"Endoceutics (R.G., F.L., A.Y.D.), Quebec City, Canada G1V 4M7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernand","family":"Labrie","sequence":"additional","affiliation":[{"name":"Endoceutics (R.G., F.L., A.Y.D.), Quebec City, Canada G1V 4M7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain Y.","family":"Dury","sequence":"additional","affiliation":[{"name":"Endoceutics (R.G., F.L., A.Y.D.), Quebec City, Canada G1V 4M7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Serra","sequence":"additional","affiliation":[{"name":"Research Program in Men\u2019s Health: Aging and Metabolism (S.Ba., R.K., G.H., K.P., Z.L., C.S., A.P., T.W.S., S.Bh.), Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Papazian","sequence":"additional","affiliation":[{"name":"Research Program in Men\u2019s Health: Aging and Metabolism (S.Ba., R.K., G.H., K.P., Z.L., C.S., A.P., T.W.S., S.Bh.), Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O\u2019Leary","sequence":"additional","affiliation":[{"name":"Department of Radiology, and Section of Urology (M.O.), Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Amr","sequence":"additional","affiliation":[{"name":"Department of Pathology (S.A.), Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Storer","sequence":"additional","affiliation":[{"name":"Research Program in Men\u2019s Health: Aging and Metabolism (S.Ba., R.K., G.H., K.P., Z.L., C.S., A.P., T.W.S., S.Bh.), Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Stern","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Functional Neuroimaging Laboratory (H.P., E.S.), Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalender","family":"Bhasin","sequence":"additional","affiliation":[{"name":"Research Program in Men\u2019s Health: Aging and Metabolism (S.Ba., R.K., G.H., K.P., Z.L., C.S., A.P., T.W.S., S.Bh.), Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,9,23]]},"reference":[{"issue":"878","key":"2020071615454684200_B1","first-page":"83","article-title":"Finasteride for benign prostatic hypertrophy","volume":"34","year":"1992","journal-title":"Med Lett Drugs Ther"},{"issue":"1021","key":"2020071615454684200_B2","first-page":"25","article-title":"Propecia and Rogaine Extra Strength for alopecia","volume":"40","year":"1998","journal-title":"Med Lett Drugs Ther"},{"issue":"13","key":"2020071615454684200_B3","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1056\/NEJM199909233411307","article-title":"Treatment of hair loss","volume":"341","author":"Price","year":"1999","journal-title":"N Engl J Med"},{"issue":"10","key":"2020071615454684200_B4","first-page":"CD006015","article-title":"Finasteride for benign prostatic hyperplasia","author":"Tacklind","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"2020071615454684200_B5","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1210\/jc.2006-2203","article-title":"The effect of 5\u03b1-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men [erratum appears in J Clin Endocrinol Metab. 2007;92(11):4379]","volume":"92","author":"Amory","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071615454684200_B6","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/jc.2003-030330","article-title":"Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5-reductase inhibitor","volume":"89","author":"Clark","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071615454684200_B7","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0022-5347(05)68270-5","article-title":"Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men","volume":"162","author":"Overstreet","year":"1999","journal-title":"J Urol"},{"issue":"17","key":"2020071615454684200_B8","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199210223271701","article-title":"The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group","volume":"327","author":"Gormley","year":"1992","journal-title":"N Engl J Med"},{"issue":"3","key":"2020071615454684200_B9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/hmbci-2015-0015","article-title":"Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia","volume":"23","author":"Traish","year":"2015","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"3","key":"2020071615454684200_B10","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1743-6109.2010.02157.x","article-title":"Adverse side effects of 5\u03b1-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients","volume":"8","author":"Traish","year":"2011","journal-title":"J Sex Med"},{"issue":"6","key":"2020071615454684200_B11","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1743-6109.2011.02255.x","article-title":"Persistent sexual side effects of finasteride for male pattern hair loss","volume":"8","author":"Irwig","year":"2011","journal-title":"J Sex Med"},{"issue":"11","key":"2020071615454684200_B12","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1111\/j.1743-6109.2012.02846.x","article-title":"Persistent sexual side effects of finasteride: could they be permanent?","volume":"9","author":"Irwig","year":"2012","journal-title":"J Sex Med"},{"issue":"6","key":"2020071615454684200_B13","doi-asserted-by":"crossref","first-page":"e10023724","DOI":"10.1371\/journal.pone.0100237","article-title":"Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia","volume":"9","author":"Di Loreto","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"2020071615454684200_B14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1557988314538445","article-title":"Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms","volume":"9","author":"Ganzer","year":"2015","journal-title":"Am J Mens Health"},{"issue":"7","key":"2020071615454684200_B15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/phar.1612","article-title":"Persistent sexual dysfunction and suicidal ideation in young men treated with low-dose finasteride: a pharmacovigilance study","volume":"35","author":"Ali","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"9","key":"2020071615454684200_B16","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4088\/JCP.12m07887","article-title":"Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects","volume":"73","author":"Irwig","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"2020071615454684200_B17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1346-8138.2002.tb00200.x","article-title":"Depression circumstantially related to administration of finasteride for androgenetic alopecia","volume":"29","author":"Altomare","year":"2002","journal-title":"J Dermatol"},{"issue":"4","key":"2020071615454684200_B18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ijir.3900857","article-title":"The International Index of Erectile Function (IIEF): a state-of-the-science review","volume":"14","author":"Rosen","year":"2002","journal-title":"Int J Impot Res"},{"issue":"4","key":"2020071615454684200_B19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.urology.2004.04.056","article-title":"Male Sexual Health Questionnaire (MSHQ): scale development and psychometric validation","volume":"64","author":"Rosen","year":"2004","journal-title":"Urology"},{"issue":"9","key":"2020071615454684200_B20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"2020071615454684200_B21","volume-title":"Beck Depression Inventory-II","author":"Beck","year":"1996"},{"issue":"4","key":"2020071615454684200_B22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","journal-title":"Br J Soc Clin Psychol"},{"issue":"6","key":"2020071615454684200_B23","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","article-title":"Development and validation of brief measures of positive and negative affect: the PANAS scales","volume":"54","author":"Watson","year":"1988","journal-title":"J Pers Soc Psychol"},{"issue":"8","key":"2020071615454684200_B24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S2213-8587(16)30102-4","article-title":"Effects of testosterone administration for 3 years on cognition in older men with low or low-normal testosterone levels: a randomized controlled trial","volume":"4","author":"Huang","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2020071615454684200_B25","volume-title":"Manual of the Eysenck Personality Questionnaire","author":"Eysenck","year":"1975"},{"key":"2020071615454684200_B26","volume-title":"SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1","author":"Ware","year":"2005","edition":"2nd ed"},{"issue":"7","key":"2020071615454684200_B27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"key":"2020071615454684200_B28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jsbmb.2015.02.009","article-title":"A rapid and sensitive UPLC-MS\/MS method for the simultaneous quantification of serum androsterone glucuronide, etiocholanolone glucuronide, and androstan-3\u03b1 17\u03b2 diol 17-glucuronide in postmenopausal women,","volume":"149","author":"Ke","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"14","key":"2020071615454684200_B29","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"9","key":"2020071615454684200_B30","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","journal-title":"Genome Res"},{"issue":"1","key":"2020071615454684200_B31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eururo.2013.08.011","article-title":"Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy","volume":"66","author":"Rajan","year":"2014","journal-title":"Eur Urol"},{"issue":"4","key":"2020071615454684200_B32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/07435800.2012.668254","article-title":"Tissue-selective regulation of androgen-responsive genes","volume":"37","author":"Otto-Duessel","year":"2012","journal-title":"Endocr Res"},{"issue":"3","key":"2020071615454684200_B33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1365-2133.1999.03030.x","article-title":"The psychological consequences of androgenetic alopecia: a review of the research literature","volume":"141","author":"Cash","year":"1999","journal-title":"Br J Dermatol"},{"issue":"6","key":"2020071615454684200_B34","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/j.1743-6109.2007.00563.x","article-title":"Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon?","volume":"4","author":"Mondaini","year":"2007","journal-title":"J Sex Med"},{"issue":"4","key":"2020071615454684200_B35","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.neuroimage.2005.03.025","article-title":"Dynamics of male sexual arousal: distinct components of brain activation revealed by fMRI","volume":"26","author":"Ferretti","year":"2005","journal-title":"Neuroimage"},{"issue":"4","key":"2020071615454684200_B36","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.neuroimage.2008.01.040","article-title":"Distinguishing specific sexual and general emotional effects in fMRI-subcortical and cortical arousal during erotic picture viewing","volume":"40","author":"Walter","year":"2008","journal-title":"Neuroimage"},{"issue":"1","key":"2020071615454684200_B37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hbm.10014","article-title":"Areas of brain activation in males and females during viewing of erotic film excerpts","volume":"16","author":"Karama","year":"2002","journal-title":"Hum Brain Mapp"},{"issue":"6","key":"2020071615454684200_B38","doi-asserted-by":"crossref","first-page":"e39118","DOI":"10.1371\/journal.pone.0039118","article-title":"Macrostructural alterations of subcortical grey matter in psychogenic erectile dysfunction","volume":"7","author":"Cera","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"2020071615454684200_B39","doi-asserted-by":"crossref","first-page":"e105336","DOI":"10.1371\/journal.pone.0105336","article-title":"Brain networks during free viewing of complex erotic movie: new insights on psychogenic erectile dysfunction","volume":"9","author":"Cera","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"2020071615454684200_B40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jad.2011.08.001","article-title":"Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder","volume":"140","author":"Sacher","year":"2012","journal-title":"J Affect Disord"},{"issue":"1","key":"2020071615454684200_B41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/npp.2009.104","article-title":"Neurocircuitry of mood disorders","volume":"35","author":"Price","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"2020071615454684200_B42","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1111\/jsm.12269","article-title":"Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious\/depressive symptomatology","volume":"10","author":"Melcangi","year":"2013","journal-title":"J Sex Med"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/12\/4669\/10528357\/jcem4669.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/101\/12\/4669\/10528357\/jcem4669.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T15:21:20Z","timestamp":1718810480000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/101\/12\/4669\/2765035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,23]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-2726","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,23]]}}}